|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.12 USD | -0.56% |
|
+3.23% | +26.25% |
| 06-12 | Cigna's Express Scripts sues to block pharmacy ownership law in Tennessee | RE |
| 06-09 | CVS Will Pay $36.5 Million to Settle Insulin Fraud Claims With State AGs, DOJ | DJ |
| Market Cap | 128B 111B 102B 95.59B 180B 12,140B 181B 1,205B 471B 5,945B 482B 472B 20,573B | P/E Ratio 2026 * |
16.1x | P/E Ratio 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 184B 159B 146B 137B 258B 17,421B 260B 1,729B 675B 8,531B 692B 677B 29,522B | EV / Sales 2026 * |
0.45x | EV / Sales 2027 * | 0.42x |
| Free-Float |
71.2% | Yield 2026 * |
2.62% | Yield 2027 * | 2.73% |
Last Transcript: CVS Health Corporation
| 1 day | -0.55% | ||
| 1 week | +3.23% | ||
| Current month | +10.13% | ||
| 1 month | +4.38% | ||
| 3 months | +32.11% | ||
| 6 months | +27.98% | ||
| Current year | +26.25% |
| 1 week | 96.13 |  | 102.77 |
| 1 month | 89.42 | | 102.77 |
| Current year | 69.51 | | 102.77 |
| 1 year | 58.5 | | 102.77 |
| 3 years | 43.56 | | 102.77 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
David Falkowski
CMP | Compliance Officer | - | 2015-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-30 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 05-30 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 05-20 | Glenview Capital Management LLC
| Sell | Company | -748,462 | 0.0584% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | +3.23% | +47.98% | +47.95% | 128B | |
| +2.40% | +6.07% | +7.88% | +37.08% | 86.51B | |
| -0.72% | +3.85% | -12.23% | +49.27% | 25.39B | |
| +0.80% | -0.10% | +12.22% | +47.42% | 22.38B | |
| +0.27% | -2.04% | +0.66% | +13.42% | 21.73B | |
| 0.00% | +1.58% | -14.24% | -22.56% | 20.4B | |
| +2.65% | +10.15% | +11.57% | +133.65% | 15.43B | |
| -0.59% | +0.81% | -5.38% | +1.14% | 14.71B | |
| -0.78% | +5.07% | +51.08% | +113.32% | 13.47B | |
| +0.38% | +5.80% | -17.42% | -5.96% | 12.68B | |
| Average | +0.42% | +5.35% | +8.21% | +41.47% | 36.12B | |
| Weighted average by Cap. | +0.51% | +5.16% | +19.65% | +41.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 353B 325B 304B 572B 38,665B 578B 3,837B 1,499B 18,935B 1,535B 1,503B 65,520B | 426B 367B 338B 317B 596B 40,267B 602B 3,996B 1,561B 19,719B 1,599B 1,565B 68,235B |
| Net income | 8.01B 6.9B 6.35B 5.96B 11.19B 757B 11.31B 75.1B 29.34B 371B 30.05B 29.42B 1,283B | 9.31B 8.03B 7.39B 6.93B 13.02B 880B 13.15B 87.34B 34.12B 431B 34.95B 34.21B 1,492B |
| Net Debt | 55.88B 48.16B 44.33B 41.58B 78.11B 5,281B 78.89B 524B 205B 2,586B 210B 205B 8,949B | 52.31B 45.09B 41.49B 38.93B 73.12B 4,944B 73.85B 491B 192B 2,421B 196B 192B 8,377B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 100.21 $ | -0.47% | 712,746 |
| 26-06-15 | 100.68 $ | -1.26% | 7,417,116 |
| 26-06-12 | 101.96 $ | +1.47% | 11,178,446 |
| 26-06-11 | 100.48 $ | +2.51% | 14,115,924 |
| 26-06-10 | 98.02 $ | +0.99% | 8,732,714 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition